Literature DB >> 3745074

Route of administration of pentobarbital affects activity of liver glycogen phosphorylase.

K J Mikines, B Sonne, E A Richter, H Galbo.   

Abstract

Liver phosphorylase a activity in intact animals is mostly determined during anesthesia. The aim of this study was to investigate the effect of administering pentobarbital by different routes on activity of liver phosphorylase a. Rats had chronically implanted venous catheters and received pentobarbital (5 mg/100 g body wt) either intraperitoneally, as a slow intravenous infusion, or as an intravenous or intracardial bolus. Times from administration of barbiturate to sampling of the liver were 10 min, 10 min, 85 +/- 32 s (mean +/- SE), and 53 +/- 10 s, respectively. Phosphorylase a activity in % of total phosphorylase activity was 40 +/- 2, 56 +/- 4, 82 +/- 3, and 92 +/- 2, respectively, all significantly different. Thus the route of administration of pentobarbital affects the phosphorylase a activity and should be considered when evaluating this activity. This fact can only be partially explained by differences in duration before the drug takes effect. It is proposed that intraperitoneal injection of pentobarbital may anesthetize hepatic sympathetic nerves or have a direct inhibiting effect on phosphorylase a activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3745074     DOI: 10.1152/jappl.1986.61.2.804

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  2 in total

1.  Involvement of interleukin-1 in the inhibition of in vivo insulin release: possible role of adrenal glands.

Authors:  H Shimizu; Y Uehara; Y Shimomura; M Negishi; I Kobayashi; S Kobayashi
Journal:  J Endocrinol Invest       Date:  1991-05       Impact factor: 4.256

2.  Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs.

Authors:  Tracy P Torres; Noriyasu Sasaki; E Patrick Donahue; Brooks Lacy; Richard L Printz; Alan D Cherrington; Judith L Treadway; Masakazu Shiota
Journal:  J Pharmacol Exp Ther       Date:  2011-03-01       Impact factor: 4.030

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.